GLP-1 tirzepatide may be considered for adults who have struggled with weight despite lifestyle changes, have weight-related or metabolic health concerns, prefer non-surgical medical weight loss options, and meet eligibility criteria after medical evaluation
Different carriers and additives in various products affect skin tolerance
We selected reviews, clinical trials, and basic research articles from the past 5 years
Key facts: Weekly injection at higher doses than Ozempic
Nat Rev Endocrinol 8:728742 Rosenstock J, Raccah D, Koranyi L et al (2013) Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)